A carregar...

Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents

BACKGROUND: The risk for cardiovascular events associated with systemic therapies for psoriasis, including biologics, is unclear. METHODS: We used administrative data from Medicare 2006 through 2011 to identify psoriasis patients who initiated systemic treatments. We estimated incidence rates of hos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Psoriasis Psoriatic Arthritis
Main Authors: Curtis, Jeffrey R., Danila, Maria I., Chen, Lang, Chan, Benjamin, Ehst, Ben, Xie, Fenglong, Winthrop, Kevin L., Yun, Huifeng
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5800414/
https://ncbi.nlm.nih.gov/pubmed/29423460
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!